Good Morning, Day Two!

Following a thrilling first day in milano at the fieramilano exhibition space, CPhI gets underway for day two and the QUINTA-ANALYTICA team are fired up and raring to go.

Yesterday was jam-packed with catch-ups and meetings, and today promises to be equally as exciting. If you’re here at #cphiww be sure to call by stand 4K46 subevent ICSE, CRO & Clinical Trials Zone to say hello.

‍

Additional News

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.

  • 11 September 2025

    Meet us at CPHI 2025

    This October, the global pharmaceutical community will gather in Frankfurt for CPHI 2025. Quinta-Analytica as a member of Conscio Group will be there too – visit us in the Contract Manufacturing Hall 5.1, Stand F1.

  • 8 September 2025

    Quinta-Analytica successfully passed two onsite FDA inspections

    In the first half of 2025, Quinta-Analytica underwent two onsite inspections by the U.S. Food and Drug Administration (FDA).

ALL POSTS